187 related articles for article (PubMed ID: 7913437)
1. [Proliferating cell nuclear antigen/cyclin (PCNA/Cyclin) in thyroid carcinoma].
Xu YJ
Zhonghua Wai Ke Za Zhi; 1993 Oct; 31(10):628-9. PubMed ID: 7913437
[TBL] [Abstract][Full Text] [Related]
2. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
3. Proliferative activity of human thyroid tumors evaluated by proliferating cell nuclear antigen/cyclin immunohistochemical studies.
Shimizu T; Usuda N; Yamanda T; Sugenoya A; Iida F
Cancer; 1993 May; 71(9):2807-12. PubMed ID: 8096795
[TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen (PCNA) in medullary thyroid carcinoma.
Skopelitou A; Korkolopoulou P; Papanikolaou A; Hadjiyannakis M
J Cancer Res Clin Oncol; 1993; 119(7):379-81. PubMed ID: 8098331
[TBL] [Abstract][Full Text] [Related]
5. Cell proliferation of transitional cell bladder cancer determined by PCNA/cyclin immunostaining. A histopathological description.
Lipponen PK; Eskelinen MJ
Anticancer Res; 1992; 12(2):577-83. PubMed ID: 1349799
[TBL] [Abstract][Full Text] [Related]
6. The proliferative fraction in lymph nodes: a comparison of proliferating cell nuclear antigen morphometry to flow cytometry.
Krauss JS; Pantazis CG; Chandler FW
Ann Clin Lab Sci; 1992; 22(3):189-96. PubMed ID: 1354428
[TBL] [Abstract][Full Text] [Related]
7. Expression of proliferating cell nuclear antigen in invasive ductal carcinoma of the breast.
Horiguchi J; Iino Y; Takei H; Morishita Y; Nakajima T
Jpn J Clin Oncol; 1994 Apr; 24(2):79-84. PubMed ID: 7908995
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of proliferating cell nuclear antigen (PCNA) in endometrial carcinoma with argyrophil cells.
Ueda G; Sawada M; Ogawa H; Tanizawa O; Tsujimoto M
Gynecol Oncol; 1993 Mar; 48(3):314-6. PubMed ID: 8096489
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: comparison with clinical and pathologic variables.
Frierson HF
Mod Pathol; 1993 May; 6(3):290-4. PubMed ID: 8102204
[TBL] [Abstract][Full Text] [Related]
10. Proliferating cell nuclear antigen in archival surgical specimens of malignant lymphoma and metastatic carcinoma: immunohistochemical and flow cytometric analysis.
Gorczyca W; Kram A; Tuziak T; Darzynkiewicz Z; Melamed MR
Patol Pol; 1993; 44(3):121-8. PubMed ID: 7902557
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
Narita T; Funahashi H; Satoh Y; Takagi H
Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256
[TBL] [Abstract][Full Text] [Related]
12. HLA and thyroid carcinoma.
Ahuja S; Hoppe I; von Keyserlingk H; Ernst H
Exp Clin Endocrinol; 1992; 99(3):134-6. PubMed ID: 1526261
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical evidence for the expression of proliferating cell nuclear antigen (PCNA) by non-proliferating hepatocytes adjacent to metastatic tumours and in inflammatory conditions.
Harrison RF; Reynolds GM; Rowlands DC
J Pathol; 1993 Oct; 171(2):115-22. PubMed ID: 7904308
[TBL] [Abstract][Full Text] [Related]
14. [Proliferating cell nuclear antigen (PCNA/cyclin) in gastric carcinoma in relation to its prognosis].
Li N
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):34-6. PubMed ID: 8101481
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical detection of cell proliferation-related antigens in cytologic smears of human malignant neoplasms using PC10, reactive with proliferating cell nuclear antigen, and Ki-67. A comparative study.
Pelosi G; Bresaola E; Manfrin E; Rodella S; Schiavon I; Iannucci A
Arch Pathol Lab Med; 1994 May; 118(5):510-6. PubMed ID: 7910728
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers.
Delahunt B; Bethwaite PB; Nacey JN; Ribas JL
J Pathol; 1993 Aug; 170(4):471-7. PubMed ID: 8105046
[TBL] [Abstract][Full Text] [Related]
17. Tumor proliferation-related markers in papillary thyroid carcinomas: correlation with histologic subtypes.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Nakamura S; Hashimoto T
Anticancer Res; 1993; 13(1):267-71. PubMed ID: 8097390
[TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical study of proliferating cell nuclear antigen (PCNA) in gynecological tumors and their related lesions].
Sawada M; Ueda G; Inoue M; Shimizu H; Ogawa H; Nakazawa A; Fujita M; Tanizawa O; Tsujimoto M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):181-7. PubMed ID: 1347557
[TBL] [Abstract][Full Text] [Related]
19. Comparative flow cytometric analysis of proliferating cell nuclear antigen (PCNA) antibodies in human solid neoplasms.
Teague K; el-Naggar A
Cytometry; 1994 Jan; 15(1):21-7. PubMed ID: 7909288
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical identification of proliferative hepatocytes using monoclonal antibody to proliferating cell nuclear antigen (PCNA/cyclin). Comparison with immunocytochemical staining for DNA polymerase-alpha.
Kawakita N; Seki S; Yanai A; Sakaguchi H; Kuroki T; Mizoguchi Y; Kobayashi K; Monna T
Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S14-20. PubMed ID: 1374217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
